Eledon Pharmaceuticals (ELDN) Treasury Shares (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Treasury Shares of $110086.0 for Q1 2026, little changed on a QoQ basis from $110086.0 in Q4 2025, and little changed year-over-year from $110086.0 in Q1 2025.
Eledon Pharmaceuticals (ELDN) Treasury Shares (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Treasury Shares history runs 12 years deep, the most recent figure standing at $110086.0 for Q1 2026.
- Quarterly Treasury Shares changed 0.0% year-over-year to $110086.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110086.0 (changed 0.0% YoY) and the FY2025 annual result came in at $110086.0, changed 0.0% from the prior year.
- Treasury Shares was $110086.0 for Q1 2026 at Eledon Pharmaceuticals, roughly flat from $110086.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $110086.0 in Q1 2024 and bottomed at $4422.0 in Q4 2023.
- A 5-year average of $82230.2 and a median of $110086.0 in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares soared 2389.51% — and 2025, when it slumped 95.98%.
- Eledon Pharmaceuticals' Treasury Shares stood at $15000.0 in 2022, then sank by 70.52% to $4422.0 in 2023, then surged by 2389.51% to $110086.0 in 2024, then changed by 0.0% to $110086.0 in 2025, then changed by 0.0% to $110086.0 in 2026.
- Business Quant data shows ELDN's Treasury Shares at $110086.0 in Q1 2026, $110086.0 in Q4 2025, and $4422.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 468.98 Bn | 464.19 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 123.24 Bn | 115.99 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.45 Bn | 61.70 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 63.04 Bn | 63.04 Bn | - | - |
| 8 | Argenx Se | 55.79 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | - |
| 10 | Eledon Pharmaceuticals | 405.99 Mn | 405.99 Mn | - | 110,086.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110,086.00 |
| Mar 31, 2026 | 110,086.00 |
| Dec 31, 2025 | 110,086.00 |
| Dec 31, 2025 | 110,086.00 |
| Sep 30, 2025 | 4,422.00 |
| Sep 30, 2025 | 4,422.00 |
| Jun 30, 2025 | 110,086.00 |
| Jun 30, 2025 | 110,086.00 |
| Mar 31, 2025 | 110,086.00 |
| Mar 31, 2025 | 110,086.00 |
| Dec 31, 2024 | 110,086.00 |
| Dec 31, 2024 | 110,086.00 |
| Sep 30, 2024 | 110,086.00 |
| Sep 30, 2024 | 110,086.00 |
| Jun 30, 2024 | 110,086.00 |
| Jun 30, 2024 | 110,086.00 |
| Mar 31, 2024 | 110,086.00 |
| Mar 31, 2024 | 110,086.00 |
| Dec 31, 2023 | 4,422.00 |
| Dec 31, 2023 | 4,422.00 |